Review



polyclonal rabbit anti-human mtap antibody  (GeneTex)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GeneTex polyclonal rabbit anti-human mtap antibody
    Polyclonal Rabbit Anti Human Mtap Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-human mtap antibody/product/GeneTex
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human mtap antibody - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    90
    Thermo Fisher polyclonal rabbit anti-human mtap antibody
    Clinical pathological features of 165 patients with advanced-stage non-small cell lung cancer.
    Polyclonal Rabbit Anti Human Mtap Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-human mtap antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human mtap antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    GeneTex polyclonal rabbit anti-human mtap antibody
    Clinical pathological features of 165 patients with advanced-stage non-small cell lung cancer.
    Polyclonal Rabbit Anti Human Mtap Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-human mtap antibody/product/GeneTex
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human mtap antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Clinical pathological features of 165 patients with advanced-stage non-small cell lung cancer.

    Journal: Scientific Reports

    Article Title: MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

    doi: 10.1038/s41598-020-57812-2

    Figure Lengend Snippet: Clinical pathological features of 165 patients with advanced-stage non-small cell lung cancer.

    Article Snippet: The primary polyclonal rabbit anti-human MTAP antibody (1:500; Thermo Fisher Scientific, US) and secondary antibody were applied to stain the slides.

    Techniques: Expressing, Mutagenesis

    Clinical response of first-line therapy for 165 patients and associations with  MTAP  expression.

    Journal: Scientific Reports

    Article Title: MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

    doi: 10.1038/s41598-020-57812-2

    Figure Lengend Snippet: Clinical response of first-line therapy for 165 patients and associations with MTAP expression.

    Article Snippet: The primary polyclonal rabbit anti-human MTAP antibody (1:500; Thermo Fisher Scientific, US) and secondary antibody were applied to stain the slides.

    Techniques: Expressing

    Progression-free survival curve of patients stratified by MTAP expression. The median PFS in the MTAP-low group was 8.1 months, compared to 13.1 months in the MTAP-high group ( p = 0.002).

    Journal: Scientific Reports

    Article Title: MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

    doi: 10.1038/s41598-020-57812-2

    Figure Lengend Snippet: Progression-free survival curve of patients stratified by MTAP expression. The median PFS in the MTAP-low group was 8.1 months, compared to 13.1 months in the MTAP-high group ( p = 0.002).

    Article Snippet: The primary polyclonal rabbit anti-human MTAP antibody (1:500; Thermo Fisher Scientific, US) and secondary antibody were applied to stain the slides.

    Techniques: Expressing

    Overall survival curve of patients stratified by MTAP expression. The median OS was 22 months in the MTAP-low group, whereas it was 32 months in the MTAP-high group ( p = 0.044). The 1- and 2-year survival were higher in the MTAP-high group (88.8% vs. 79.5%; 67.8% vs. 40.7%, respectively).

    Journal: Scientific Reports

    Article Title: MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

    doi: 10.1038/s41598-020-57812-2

    Figure Lengend Snippet: Overall survival curve of patients stratified by MTAP expression. The median OS was 22 months in the MTAP-low group, whereas it was 32 months in the MTAP-high group ( p = 0.044). The 1- and 2-year survival were higher in the MTAP-high group (88.8% vs. 79.5%; 67.8% vs. 40.7%, respectively).

    Article Snippet: The primary polyclonal rabbit anti-human MTAP antibody (1:500; Thermo Fisher Scientific, US) and secondary antibody were applied to stain the slides.

    Techniques: Expressing

    Univariate and Multivariable analyses of overall survival.

    Journal: Scientific Reports

    Article Title: MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab

    doi: 10.1038/s41598-020-57812-2

    Figure Lengend Snippet: Univariate and Multivariable analyses of overall survival.

    Article Snippet: The primary polyclonal rabbit anti-human MTAP antibody (1:500; Thermo Fisher Scientific, US) and secondary antibody were applied to stain the slides.

    Techniques: Mutagenesis, Expressing